Attached files
file | filename |
---|---|
8-K - 8-K - HUMANIGEN, INC | v427633_8k.htm |
Exhibit 16.1
December 23, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by KaloBios Pharmaceuticals, Inc. under Item 4.01 of its Form 8-K dated December 21, 2015. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of KaloBios Pharmaceuticals, Inc. contained therein.
Very truly yours,